Xiaolan Wu

1.7k total citations
45 papers, 1.4k citations indexed

About

Xiaolan Wu is a scholar working on Molecular Biology, Pharmacology and Plant Science. According to data from OpenAlex, Xiaolan Wu has authored 45 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 12 papers in Pharmacology and 11 papers in Plant Science. Recurrent topics in Xiaolan Wu's work include Natural product bioactivities and synthesis (13 papers), Ginseng Biological Effects and Applications (12 papers) and Pharmacological Effects of Natural Compounds (9 papers). Xiaolan Wu is often cited by papers focused on Natural product bioactivities and synthesis (13 papers), Ginseng Biological Effects and Applications (12 papers) and Pharmacological Effects of Natural Compounds (9 papers). Xiaolan Wu collaborates with scholars based in China, United States and Japan. Xiaolan Wu's co-authors include Sachie Kishitani, Yukihiro Ito, Kinya Toriyama, Guangji Wang, Fang Zhou, Jingwei Zhang, Haiping Hao, Gang Hao, Jianguo Sun and Fang Niu and has published in prestigious journals such as PLoS ONE, British Journal of Pharmacology and Journal of Ethnopharmacology.

In The Last Decade

Xiaolan Wu

41 papers receiving 1.4k citations

Peers

Xiaolan Wu
Daih‐Huang Kuo Taiwan
Pengfei Tu China
Young‐Mi Kim South Korea
Xiaolan Cheng China
Ean‐Jeong Seo Germany
Baolin Bian China
Shanshan Wei China
Hua‐Wu Zeng China
Junting Fan China
Daih‐Huang Kuo Taiwan
Xiaolan Wu
Citations per year, relative to Xiaolan Wu Xiaolan Wu (= 1×) peers Daih‐Huang Kuo

Countries citing papers authored by Xiaolan Wu

Since Specialization
Citations

This map shows the geographic impact of Xiaolan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolan Wu more than expected).

Fields of papers citing papers by Xiaolan Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaolan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolan Wu. The network helps show where Xiaolan Wu may publish in the future.

Co-authorship network of co-authors of Xiaolan Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaolan Wu. A scholar is included among the top collaborators of Xiaolan Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaolan Wu. Xiaolan Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Deng, Yang, Jing Du, Xin He, et al.. (2025). Risk assessment of CYP3A induction by ginsenoside’s metabolites from oral Panax notoginseng (sanqi) extract. Journal of Ethnopharmacology. 349. 119864–119864.
3.
Yang, Kailin, Liuting Zeng, Xiaolan Wu, et al.. (2023). Uncovering the pharmacological mechanism of Shou Tai Wan on recurrent spontaneous abortion: A integrated pharmacology strategy-based research. Journal of Ethnopharmacology. 323. 117589–117589.
4.
Wu, Xiaolan, et al.. (2015). The isolation and structural elucidation of three new biflavonoid glycosides fromLomatogonium carinthiacum. Natural Product Research. 29(14). 1358–1362. 6 indexed citations
5.
Wu, Xiaolan, et al.. (2014). A biflavonoid glycoside fromLomatogonium carinthiacum(Wulf) Reichb. Natural Product Research. 29(1). 77–81. 6 indexed citations
6.
Wu, Xiaolan. (2013). Expression of Eotaxin and its correlation with pulmonary function in patients with cough variant asthma. Shiyong yixue zazhi. 1 indexed citations
7.
Cao, Bei, Mengjie Li, Weibin Zha, et al.. (2013). Metabolomic approach to evaluating adriamycin pharmacodynamics and resistance in breast cancer cells. Metabolomics. 9(5). 960–973. 65 indexed citations
8.
Ao, Wuliji, et al.. (2012). Lignans fromSyringa pinnatifoliaHemsl. Var.alashanensis. Journal of Asian Natural Products Research. 14(4). 396–400. 18 indexed citations
9.
Zhang, Jingwei, Fang Zhou, Fang Niu, et al.. (2012). Stereoselective Regulations of P-Glycoprotein by Ginsenoside Rh2 Epimers and the Potential Mechanisms From the View of Pharmacokinetics. PLoS ONE. 7(4). e35768–e35768. 35 indexed citations
10.
Zhang, Jingwei, Meng Lu, Fang Zhou, et al.. (2012). Key Role of Nuclear Factor-κB in the Cellular Pharmacokinetics of Adriamycin in MCF-7/Adr Cells: The Potential Mechanism for Synergy with 20(S)-Ginsenoside Rh2. Drug Metabolism and Disposition. 40(10). 1900–1908. 37 indexed citations
11.
Li, Hao, Ya Cao, Xiaolan Wu, Zonghuang Ye, & Genxi Li. (2012). Peptide-based electrochemical biosensor for amyloid β 1–42 soluble oligomer assay. Talanta. 93. 358–363. 77 indexed citations
12.
Zhang, Jingwei, Fang Zhou, Xiaolan Wu, et al.. (2011). Cellular pharmacokinetic mechanisms of adriamycin resistance and its modulation by 20(S)‐ginsenoside Rh2 in MCF‐7/Adr cells. British Journal of Pharmacology. 165(1). 120–134. 81 indexed citations
13.
An, Kang, Haiping Hao, Xiao Zheng, et al.. (2011). Peripheral anti-inflammatory effects explain the ginsenosides paradox between poor brain distribution and anti-depression efficacy. Journal of Neuroinflammation. 8(1). 100–100. 90 indexed citations
14.
Zhou, Fang, Jingwei Zhang, Peng Li, et al.. (2011). Toward a new age of cellular pharmacokinetics in drug discovery. Drug Metabolism Reviews. 43(3). 335–345. 44 indexed citations
15.
Zhang, Jingwei, Fang Zhou, Xiaolan Wu, et al.. (2010). 20(S)-Ginsenoside Rh2 Noncompetitively Inhibits P-Glycoprotein In Vitro and In Vivo: A Case for Herb-Drug Interactions. Drug Metabolism and Disposition. 38(12). 2179–2187. 92 indexed citations
16.
Zheng, Yuanting, Fang Zhou, Xiaolan Wu, et al.. (2010). 23-Hydroxybetulinic acid from Pulsatilla chinensis (Bunge) Regel synergizes the antitumor activities of doxorubicin in vitro and in vivo. Journal of Ethnopharmacology. 128(3). 615–622. 53 indexed citations
17.
Wu, Xiaolan, et al.. (2008). Enhanced heat and drought tolerance in transgenic rice seedlings overexpressing OsWRKY11 under the control of HSP101 promoter. Plant Cell Reports. 28(1). 21–30. 389 indexed citations
18.
Zheng, Yuanting, Guangji Wang, Xiaolan Wu, et al.. (2007). Quantitative analysis of 23‐hydroxybetulinic acid, a novel anticancer substance, in the cellular environment of a human colon adenocarcinoma cell line for cellular pharmacokinetic studies. Rapid Communications in Mass Spectrometry. 21(5). 779–786. 2 indexed citations
19.
Wu, Xiaolan, Mingmei Cao, Wei Pan, et al.. (2003). Selection of trkB-binding peptides from a phage-displayed random peptide library. Science in China Series C Life Sciences. 46(1). 77–86. 5 indexed citations
20.
Wang, Yongxin, et al.. (1987). The radioimmunoimaging of tumor-beared mouse by 125 I-labelled monoclonal anti-HCG-β antibodies. Nuclear Techniques. 10(10). 50–52. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daih‐Huang Kuo Breakdown of academic impact, for papers by Pengfei Tu Breakdown of academic impact, for papers by Young‐Mi Kim Breakdown of academic impact, for papers by Xiaolan Cheng Breakdown of academic impact, for papers by Ean‐Jeong Seo Breakdown of academic impact, for papers by Baolin Bian Breakdown of academic impact, for papers by Shanshan Wei Breakdown of academic impact, for papers by Hua‐Wu Zeng Breakdown of academic impact, for papers by Junting Fan
Rankless by CCL
2026